Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04745234
Title Mogamulizumab Q4week Dosing in Participants With R/R CTCL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kyowa Kirin, Inc.
Indications

Sezary's disease

mycosis fungoides

Therapies

Mogamulizumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP


No variant requirements are available.